NWBO
Northwest Biotherapeutics, Inc. Common stock
NWBO
NWBO
Delisted
NWBO was delisted on the 16th of December, 2016.
54 hedge funds and large institutions have $18.3M invested in Northwest Biotherapeutics, Inc. Common stock in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
53% less call options, than puts
Call options by funds: $110K | Put options by funds: $233K
63% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 16
Holders
54
Holding in Top 10
1
Calls
$110K
Puts
$233K
Top Buyers
| 1 | +$113K | |
| 2 | +$110K | |
| 3 | +$26.2K | |
| 4 |
Goldman Sachs
New York
|
+$19.7K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$14.1K |
Top Sellers
| 1 | -$512K | |
| 2 | -$495K | |
| 3 | -$129K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$124K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$109K |